Fuji Pharma Co (FRA:FUP) Total Liabilities: €253.9 Mil (As of Mar. 2026)


FRA:FUP Fuji Pharma Co Ltd FRA:FUP
86 GF Score
Price €10.40
GF Value €9.59
! 3 Warning Signs
View Full Analysis

What is Fuji Pharma Co Total Liabilities?

Fuji Pharma Co FRA:FUP -2.80% 86 Total Liabilities is €253.9 Mil as of Mar. 2026. GuruFocus rates FRA:FUP with a GF Score™ of 86/100 and a GF Value™ of €9.59. The stock has 3 warning signs investors should review.

Fuji Pharma Co's Total Liabilities for the quarter that ended in Mar. 2026 was €253.9 Mil.

Fuji Pharma Co's quarterly Total Liabilities declined from Sep. 2025 (€267.94 Mil) to Dec. 2025 (€258.15 Mil) and declined from Dec. 2025 (€258.15 Mil) to Mar. 2026 (€253.90 Mil).

Fuji Pharma Co's annual Total Liabilities increased from Sep. 2023 (€279.86 Mil) to Sep. 2024 (€280.09 Mil) but then declined from Sep. 2024 (€280.09 Mil) to Sep. 2025 (€267.94 Mil).

Fuji Pharma Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Fuji Pharma Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuji Pharma Co Total Liabilities Chart

Fuji Pharma Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 243.51 280.09 279.86 280.09 267.94

Fuji Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 291.30 287.94 267.94 258.15 253.90
FRA:FUP
86GF Score
Fuji Pharma Co Ltd FRA:FUP
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuji Pharma Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Fuji Pharma Co's Total Liabilities for the fiscal year that ended in Sep. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=178.556+(75.334+1.284
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+12.763+0)
=267.9

Total Liabilities=Total Assets (A: Sep. 2025 )-Total Equity (A: Sep. 2025 )
=538.208-270.271
=267.9

Fuji Pharma Co's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=176.039+(64.471+1.046
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+12.347+0)
=253.9

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=533.873-279.97
=253.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €253.9 Mil mean?
Fuji Pharma Co (FRA:FUP) has a Total Liabilities of €253.9 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Fuji Pharma Co and its competitors.
Is Fuji Pharma Co's Total Liabilities too high?
Fuji Pharma Co's current Total Liabilities is €253.9 Mil. Overall, Fuji Pharma Co has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Fuji Pharma Co's Total Liabilities compare to ZTS and UTHR?
Fuji Pharma Co's Total Liabilities of €253.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Fuji Pharma Co and its competitors. Fuji Pharma Co's current Total Liabilities is €253.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuji Pharma Co stock overvalued right now?
Fuji Pharma Co (FRA:FUP) has a current Total Liabilities of €253.9 Mil. The stock's GF Value™ is €9.59, compared to a current price of €10.40 — trading 8.4% above its estimated fair value. The current Total Liabilities is €253.9 Mil. Fuji Pharma Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Fuji Pharma Co (FRA:FUP), the current Total Liabilities is €253.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuji Pharma Co (FRA:FUP) Overvalued in 2026?

Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued. The current stock price of €10.40 is trading 8.4% above its estimated GF Value™ of €9.59.

Key valuation signals for FRA:FUP:

  • Total Liabilities: €253.9 Mil
  • GF Value™: €9.59 vs. price of €10.40 (8.4% above fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the FRA:FUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuji Pharma Co Business Description

Other Exchanges 4554:Japan
Address 5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
86GF Score

Get the complete analysis for FRA:FUP

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.40
Price
€9.59
GF Value